Psilera, a US-based biotechnology company, announced on Tuesday that it has named Magali Haas, MD, PhD as its new director.
Presently, Dr Haas works as founder and chair of Cohen Veterans Bioscience and has earlier served as CEO & president for ten years. She has set up Brain Health Nexus, a global initiative focused on operationalising brain health through the development, validation and adoption of a global brain health index.
Dr Chris Witowski, Psilera CEO, said: "We are thrilled to welcome Magali as an independent member of our board of directors. Her extensive background in neuroscience and experience translating early-stage research and clinical development align perfectly with our mission at Psilera."
Renew Biotechnologies names new chief operating officer
Teva, Sanofi accelerate inflammatory bowel disease drug trial
Ro adds David B Allison to Advisory Board
Charles River Laboratories and Autobahn Labs forge alliance to boost academic drug discovery
Nkarta partnering with Columbia on investigator-led lupus trial for NKX019
Gilead's lenacapavir demonstrates 100% efficacy in HIV prevention trial
Anixa Biosciences' ovarian cancer CAR-T therapy individual patient IND receives FDA approval
Evergreen Nephrology names new director
Emmaus Life Sciences names new chief executive officer
FDA feedback boosts Diamyd Medical's pathway to accelerated approval for Type 1 Diabetes Therapy
TC BioPharm (Holdings) doses sixth patient in TCB-008 clinical trial
Caidya names new chief executive officer
Ionis Pharmaceuticals reports positive results for ION582 in Angelman syndrome study
Nuvalent launches HEROEX-1 trial for HER2-selective inhibitor NVL-330
Astellas and Osaka University collaborate on stem cell therapy for disc degeneration